Advertisement
Novara — A Smarter Way to Access Global Markets
Markets desk·updated through the day

Equities

Stock market news from the SIX and SMI, the DAX and ATX, and European shares, with the global moves that drive them.

Holcim Shares Extend Decline Despite Stronger 2026 Outlook and Earnings
EquitiesArticle

Holcim Shares Extend Decline Despite Stronger 2026 Outlook and Earnings

The Swiss building materials group's stock fell 3.5 percent over the week, mirroring broader sector weakness driven by energy costs and high interest rates.

Markets Desk · 2 Oct 2026
Zurich Insurance Shares Face Declines Amid Broader Market Pressures
EquitiesArticle

Zurich Insurance Shares Face Declines Amid Broader Market Pressures

Zurich Insurance shares head toward a fifth consecutive daily loss, reflecting a wider downturn across Swiss and global financial equities.

Markets Desk · 2 Oct 2026
Julius Baer Launches CHF 600 Million Share Buyback and Updates Capital Policy
EquitiesArticle

Julius Baer Launches CHF 600 Million Share Buyback and Updates Capital Policy

The Swiss wealth management group announced a share buyback program of up to CHF 600 million alongside a revised capital distribution policy targeting a CET1 ratio of 15%.

Markets Desk · 2 Oct 2026
Frankfurt Stocks Close: DAX Slips Below 25,000 Points as 200-Day Moving Average Holds
EquitiesArticle

Frankfurt Stocks Close: DAX Slips Below 25,000 Points as 200-Day Moving Average Holds

The German DAX fell 1.03% to close below 25,000 points on Thursday, finding temporary support at its 200-day moving average amid pressure from high oil prices, rising bond yields, and weak US markets.

Markets Desk · 2 Oct 2026
DAX Closes Lower as Inflation Concerns Offset Positive US Data
EquitiesArticle

DAX Closes Lower as Inflation Concerns Offset Positive US Data

Germany's DAX index dropped 0.79 percent on Wednesday, finishing a weak September in negative territory as persistent domestic inflation overshadowed favorable US economic reports.

Markets Desk · 1 Oct 2026
JPMorgan Buys Into Struggling Swiss Biotech Kuros Despite 34% Year-to-Date Slide
EquitiesArticle

JPMorgan Buys Into Struggling Swiss Biotech Kuros Despite 34% Year-to-Date Slide

Wall Street giant expands stake to over 5% in Kuros Biosciences as stock trails 2024's top Swiss performer. UBS also flags Swiss names among its top European tactical picks.

Markets Desk · 30 Sept 2026
BMW Unveils Major Restructuring, Targets 8-10% ROE by Early 2030s
EquitiesArticle

BMW Unveils Major Restructuring, Targets 8-10% ROE by Early 2030s

BMW announced a broad corporate overhaul on Wednesday, including 8,000 job cuts in Munich and a localized product strategy, aiming to restore profitability after a tough period.

Markets Desk · 30 Sept 2026
EuroStoxx 50 climbs 0.3% as investors stay upbeat amid oil and bond yields
EquitiesArticle

EuroStoxx 50 climbs 0.3% as investors stay upbeat amid oil and bond yields

The EuroStoxx 50 rose to 6,320.26 points, led by a 4.2% gain in ASML, while Swiss and UK benchmarks showed mixed moves. Analysts cite optimism on Middle‑East de‑escalation and tech growth.

Markets Desk · 30 Sept 2026
DocMorris shares rise 10% as target raised, Redcare lagging
EquitiesArticle

DocMorris shares rise 10% as target raised, Redcare lagging

DocMorris stock has doubled year‑to‑date after a 10% jump, with Research Partners lifting its price target to CHF 14.60. Analyst compares it with slower‑gaining rival Redcare Pharmacy.

Markets Desk · 30 Sept 2026
DAX slips 0.13% to 25,374 as US weakness drags German shares
EquitiesArticle

DAX slips 0.13% to 25,374 as US weakness drags German shares

The German DAX closed at 25,374.42 points, down 0.13%, after late‑day losses tied to weak US markets, rising oil and gold prices and concerns over AI sector funding.

Markets Desk · 29 Sept 2026
Calida lifts dividend and launches 2% share buyback, but analysts stay cautious
EquitiesArticle

Calida lifts dividend and launches 2% share buyback, but analysts stay cautious

Swiss apparel group Calida announced a dividend payout increase to 40‑60% of adjusted earnings and a share repurchase of up to 2% of capital. Analysts say the moves improve returns but urge faster brand investment.

Markets Desk · 28 Sept 2026
Roche's Pharma Day Targets Fail to Win Over Investors
EquitiesArticle

Roche's Pharma Day Targets Fail to Win Over Investors

The Swiss drugmaker unveiled ambitious R&D goals and cost-cutting plans, but shares slipped as investors remained unimpressed with the outlook.

Markets Desk · 28 Sept 2026
European stocks stay flat as Iran tensions lift oil, bond yields and hit tech shares
EquitiesArticle

European stocks stay flat as Iran tensions lift oil, bond yields and hit tech shares

The Swiss Market Index edged up 0.06% while the DAX and EuroStoxx50 were unchanged; Brent rose to $108 and 10‑year German yields hit 3.65% amid geopolitical risk and AI concerns.

Markets Desk · 28 Sept 2026
Helvetia Introduces VivaFlex for Flexible Private Pensioning
EquitiesArticle

Helvetia Introduces VivaFlex for Flexible Private Pensioning

Swiss insurer Helvetia launches VivaFlex, a new life insurance product designed to adapt to evolving life stages, including part-time work and career transitions.

Markets Desk · 28 Sept 2026
Roche pushes aggressive pipeline expansion at Pharma Day, cites AI and new "Bar" criteria
EquitiesArticle

Roche pushes aggressive pipeline expansion at Pharma Day, cites AI and new "Bar" criteria

Roche outlined a goal of up to 20 new drugs by 2030, introduced a stricter "Bar" framework for candidate selection and highlighted artificial‑intelligence integration across research, aiming for >30 bn CHF sales from top prospects.

Markets Desk · 28 Sept 2026
Bernstein Names Sonova, Alcon Top European Medtech Picks for H2
EquitiesArticle

Bernstein Names Sonova, Alcon Top European Medtech Picks for H2

The firm highlighted Sonova as its short-term top pick and Alcon as the preferred long-term play, citing strong fundamentals in hearing aids and ophthalmology.

Markets Desk · 25 Sept 2026
SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms
EquitiesArticle

SMI holds steady; UBS, Givaudan in demand; Semiconductor stocks rise; Nestlé underperforms

Swiss stock market shows slight gains; UBS and Givaudan see increased interest; semiconductor stocks rise; Nestlé underperforms; new ratings and price targets for Swiss stocks

Markets Desk · 25 Sept 2026
SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles
EquitiesArticle

SMI Holds Steady; ABB and UBS Rise, Nestlé Struggles

Swiss stock market shows resilience, with ABB and UBS gaining while Nestlé lags. Oil prices and bond yields remain key market drivers.

Markets Desk · 25 Sept 2026